USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
BIOCHEMANALYSIS CORPORATION
Address:
2201 W CAMPBELL PARK DR Suite 28
CHICAGO, IL
Phone:
N/A
URL:
N/A
EIN:
363801900
DUNS:
858735780
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,047,119.00 15
SBIR Phase II $3,418,553.00 4

Award List:

Measurement of Boron Stable Isotopes for Cancer Therapy

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
Development of novel boronated compounds and use of epithermal neutrons has now generated much interest in 10B-boron capture neutron therapy of different tumors. However, no suitable methods exist that allow investigation of their pharmacokinetics in human subjects or in vivo measurement of the… More

Development of Accurate Test Kits for Malabsorption

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$79,324.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
Accurate measurement of gastrointestinal absorption of various substances is important in bothresearch and diagnosis. In many cases, the acceptable general approach is the balance procedure. Thisprocedure suffers from the requirement for complete collection of stools over an extended period oftime.… More

Direct Measurement of Bone Formation/Resorption Rates

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$99,997.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
We will develop a unified experimental approach to the accurate and simultaneous measurement of bonand resorption rates applicable to all animals, including man, using stable isotopes of strontium (Sformation and resorption rates is of fundamental importance to a better understanding of bone… More

sensitive test of generalized steatorrhea

Award Year / Program / Phase:
1997 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

ACCURATE NONINVASIVE TEST OF FAT ABSORPTION IN INFANTS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$118,683.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
Not Available Nanofibers have found a market in filter applications because of their high surface area and ability to effect a large pressure drop over a small thickness. Although their use in filter applications is known, methods to produce large quantities of nanofiber sheets are kept as trade… More

MUCOSAL IRON UPTAKE AND TRANSFER IN HEMOCHROMATOSIS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$116,664.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
Not Available With the increasing consumer demand for mobile/portable systems, low power VLSI has gained great importance. A number of circuit level power reduction schemes, including supply/threshold voltage scaling, multiple threshold schemes and selective clocking are available. However, greater… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$132,205.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$131,874.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$129,043.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani
Abstract:
N/a

ACCURATE NONINVASIVE TEST OF STEATORRHEA IN INFANTS

Award Year / Program / Phase:
2002 / SBIR / Phase II
Award Amount:
$901,957.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by the applicant): The long-term objectives of this proposed project are to develop a "Test Kit" for quantitative assessment of steatorrhea in infants without the need for control of dietary fat intake and quantitative collections of stools for… More

ACCURATE NONINVASIVE TEST OF STEATORRHEA IN INFANTS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by the applicant): The long-term objectives of this proposed project are to develop a "Test Kit" for quantitative assessment of steatorrhea in infants without the need for control of dietary fat intake and quantitative collections of stools for… More

Effective Oral Iron Supplement for Pre-dialysis Patients

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$177,483.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Development of anemia is a major problem in chronic renal failure. Its prevention/early treatment with recombinant human erythropoietin (rHuEpo) during pre-dialysis phase is important. Available iron is required for efficient action of rHuEpo; iron supplements… More

Long-term Iron Needs of Renal Transplant Recipients

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$199,176.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The long-term objectives of this project are to: (a) Formulate an oral iron/ascorbic acid supplement specific to the needs of renal transplant recipients (RTxRs), (b) evaluate the efficacy of oral iron/ascorbic acid supplementation to meet the iron needs of this… More

Non-invasive Assessment of Insulin Resistance

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$202,652.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The long-term objectives of this project are to develop a novel non-invasive test of insulin resistance. The proposed test is based on the well-established principle of inverse relationship between glucose oxidation (Gox) and lipid oxidation (Lox) during… More

A Test of Iron Malabsorption in Patients with IDA

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$198,623.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Iron deficiency anemia (IDA) is a major problem among adults and elderly. In men and postmenopausal women, IDA is currently thought to result from gastrointestinal (GI) blood loss. Despite thorough GI tract evaluation, a significant number of patients are found… More

Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$207,050.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of this research is to develop a non-invasive approach for early assessment of de novo 3MH production in cancer patients as a way of assessing which patients are at high risk for future developme nt of skeletal muscle atrophy. The approach… More

A Non-Invasive Surrogate Test of OGTT to Screen for Pre-diabetes

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$204,345.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The long-term objectives of this proposal are to develop an inexpensive, totally non-invasive surrogate test for the 2-h oral glucose tolerance test (2-h OGTT) for the purpose of identifying individuals with pre-diabete s for preventive purposes. We believe that… More

Non-invasive Assessment of Insulin Resistance

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$860,517.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The overall objective of this grant is to develop a non-invasive method for assessment of insulin resistance and impaired glucose tolerance (IGT) as a measure of pre-diabetes suitable for application to large-scale scre ening studies and to individualized… More

Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$906,079.00
Agency:
HHS
Principal Investigator:
Morteza Janghorbani – 312-243-5988
Abstract:
DESCRIPTION (provided by applicant): Abstract The long-term objective of this research is to develop a non-invasive approach for assessment of de novo 3MH production in cancer patients early in the course of the disease as a way of assessing which patients are at high risk for future… More